Transcenta Company
Transcenta is a global biotherapeutic company that fully integrates antibody-based biotherapeutics discovery, R&D and manufacture.
Investors
Technology:
Biopharma, Biotechnology
Industry:
Clinical Development, Preclinical Development
Headquarters:
Huangpu, Shanghai, China
Founded Date:
2019-01-01
Employees Number:
251-500
Funding Status:
IPO
Acquisitions Number:
2
Investors Number:
20
Total Funding:
342000000
Estimated Revenue:
$1M to $10M
Last Funding Date:
2021-11-29
Last Funding Type:
Post-IPO Equity
Register and Claim Ownership